Recruiting
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
The goal of this research study is to adapt an ACT-self-help workbook to the prison setting and determine the feasibility acceptability, and effectiveness of this workbook. Participants can expect to be in the study for 13 weeks.
ClinicalTrials.gov IDNCT06162624
PhaseNA
Enrollment96
SponsorUniversity of Wisconsin, Madison
Age18 Years and older
SexALL
Conditions studied
Anxiety, Depression, Depression, Anxiety, Anxiety Disorders
About this study
The goal of this research study is to adapt an ACT-self-help workbook to the prison setting and determine the feasibility acceptability, and effectiveness of this workbook. Participants can expect to be in the study for 13 weeks.
Interventions
- Behavioral: Acceptance and Commitment Therapy (ACT) — ACT: Therapy that builds in traditional cognitive behavioral therapy principles but emphasizes different processes in behavior change. Delivered over 8 weeks of self-guided study and homework assignments.
- Behavioral: Reflective Journaling — As control condition, reflective journaling will be used.
Primary outcomes
- Eligible participants (Study duration, up to 1 year)
- Participants who choose to participate (Study duration, up to 1 year)
- Percentage of participants that complete all 8 weeks (Study duration, up to 1 year)
- Qualitative Summary of Reasons for Attrition (Study duration, up to 1 year)
- Number of Participants referred for Follow up care (Up to 13 weeks)
- Participant Satisfaction (Up to 13 weeks)
- Change in Mental Health: Flexibility (Baseline to 13 weeks)
- Change in Mental Health: Automatic Thoughts (Baseline to 13 weeks)
Eligibility information
Inclusion Criteria:
* 18 years of age or older
* Reading level of 6th grade or higher determined by the Wide Range Achievement Test
* Moderate or severe anxiety and/or depression determined by the Beck Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI)
* No active self-harm or active suicidal intent
* No scheduled transfer or release for at least three months
* Must be willing and able to participate, including having permission and ability to use study materials, such as paper and a writing utensil
Exclusion Criteria:
* Unable to provide informed consent
* Active self-harm or suicidal intent
* Scheduled transfer or release within three months
Study locations
- University of Wisconsin, Madison, Wisconsin 53705 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-09.